Sheng Wang

发表

Synthesis and evaluation of novel 1,4,7-triazacyclononane derivatives as Cu2+ and Ga3+ chelators.

Xiang Ma, Sheng Wang, Yongkang Gai, 2022, Journal of inorganic biochemistry.

Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer.

Mingyuan Gao, X. Lan, Yi Hou, 2020, Biomaterials science.

Development of Biocompatible Ene-Ligation Enabled by Prenyl-Based β-Caryophyllene with Triazoline/Selectfluor under Physiological Conditions.

Sheng Wang, Li Wang, Rui Wang, 2022, The Journal of organic chemistry.

Ultra-sensitive Nanoprobe Modified with Tumor Cell Membrane for UCL/MRI/PET Multimodality Precise Imaging of Triple-Negative Breast Cancer

Mingyuan Gao, Yongxue Zhang, X. Lan, 2020, Nano-micro letters.

Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer

Yongxue Zhang, X. Lan, Sheng Wang, 2021, Journal of Nanobiotechnology.

[18F]F-ET-OTSSP167 Targets Maternal Embryo Leucine Zipper Kinase for PET Imaging of Triple-Negative Breast Cancer.

Jia Hu, X. Lan, Sheng Wang, 2021, Molecular pharmaceutics.

Synthesis and evaluation of a class of 1,4,7-triazacyclononane derivatives as iron depletion antitumor agents.

Shasha Zhang, Xiang Ma, Sheng Wang, 2018, Bioorganic & medicinal chemistry letters.

A novel carbon-11 radiolabeled maternal embryonic leucine zipper kinase inhibitor for PET imaging of triple-negative breast cancer.

Jia Hu, X. Lan, Sheng Wang, 2021, Bioorganic chemistry.

Synthesis of a new bifunctional NODA for bioconjugation with PSMA ligand and one-step Al18F labeling.

Xiang Ma, Sheng Wang, Yongkang Gai, 2022, Bioorganic & medicinal chemistry.